Erythropoietin (Epo) is a glycoprotein hormone that is essential for erythropoiesis during adult and fetal life. The only known stimuli for Epo synthesis are hypoxia and anemia. Epo measured in umbilical cord blood reflects fetal synthesis and metabolism, because this hormone does not cross the placenta. 1 Epo levels appear to be a good indicator of the relative state of fetal oxygenation as demonstrated in various animal and human studies. [2] [3] [4] [5] In the animal model, fetal Epo has been shown to start increasing exponentially 3 hours after the onset of a hypoxic insult, 6 suggesting that it may reflect a more subacute form of hypoxia. Indeed, in recent years, elevated fetal Epo concentrations have been found in conditions associated with underlying chronic hypoxia, such as intrauterine growth restriction, 7 maternal diabetes, 8 hypertension/preeclampsia, 8 smoking, 9 and prolonged pregnancies. 10 Furthermore, Ruth et al. reported an increased risk of cerebral palsy or death in fetuses born with high Epo levels. 11 Approximately 7% to 12% of all pregnancies extend beyond term and carry an increased risk of perinatal morbidity and mortality especially after 42 weeks. 12 This may be related to several factors, including aberrations in fetal growth, abnormalities in amniotic fluid volume, uteroplacental insufficiency, and the presence of meconium. Only one previous study has examined Epo concentrations in postterm fetuses and found these to be elevated, but all those fetuses with meconium-stained amniotic fluid were excluded. 10 Because the presence of meconium is such a common finding in these pregnancies and its management is still controversial, we sought to determine Epo levels in post-term fetuses and evaluate the effect of meconiumstained amniotic fluid. The significance of meconium in term pregnancies is also in question; therefore, we also propose to carry out the same analysis for term fetuses. We hypothesized that because of a relative, chronic uteroplacental insufficiency, the post-term fetus would display greater Epo levels and that these would be further increased in the presence of meconium-stained amniotic fluid, reflecting a greater risk in this population. We also proposed a similar effect of meconium staining in term fetuses.
MATERIALS AND METHODS
Patients with otherwise uncomplicated pregnancies who delivered at the Ottawa General Hospital, a tertiary care center, were recruited into this study from October 1996 to October 1997. Inclusion criteria were as follows: adequate dating based on last menstrual period or early ultrasound, singleton pregnancy, and normal fetal growth and anatomy. We excluded patients with fetal anatomic or chromosomal anomalies, abnormal fetal heart tracings, fetal distress, abnormal
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labor or delivery complications, fetal or neonatal anemia, maternal smoking, alcohol, or other substance abuse, and maternal medical complications such as diabetes, hypertension, cardiac, or renal disease. All consecutive patients meeting these criteria during the study period were entered in the study, which was approved by the Ottawa General Hospital Research Ethics Board. A total of 116 patients were divided into five groups as follows: (1) fetuses born between 37 and 40 weeks' gestation (term) without meconium in amniotic fluid (n ϭ 37), (2) fetuses born between 41 and 43 weeks' gestation (post-term) without meconium in amniotic fluid (n ϭ 32), (3) term fetuses with meconium in amniotic fluid (n ϭ 18), (4) post-term fetuses with meconium-stained amniotic fluid (n ϭ 11), and (5) fetuses born between 40 and 41 weeks' gestation with meconium in amniotic fluid (n ϭ 18). This latter group was examined separately to insure a clearer distinction between the term and post-term groups.
Maternal demographics including age, gravidity, parity, and mode of delivery were obtained from the patient's chart. Birth outcomes including 5-minute Apgar score, birth weight, umbilical artery blood pH, and base deficit were also recorded. Pregnancies in each group were matched for presence of labor, mode of delivery, and gestational age where appropriate by selection of the next available case fulfilling these criteria.
Following delivery, fetal umbilical venous cord blood samples were collected by needle aspiration and deposited into plastic tubes on ice. Samples were centrifuged, and the serum was frozen at Ϫ80°C pending Epo analysis, which was performed blindly. Epo was measured in duplicate using a Quantikine IVD enzyme-linked immunosorbent assay kit (R&D Systems, Minneapolis, MN), and the mean value was calculated. Separate arterial cord blood samples were also taken to measure pH and base excess. Statistical analysis was performed using the one-tailed Student's t-test for comparison of two groups. Multiple groups were compared using the one-way analysis of variance followed by Tukey's test. All group analyses were performed after assignment of study subjects into discrete groups. Statistical significance was inferred at p Ͻ 0.05. Epo levels are expressed as mean Ϯ SEM.
RESULTS
Cord blood samples from 116 fetuses were obtained and analyzed. Maternal demographics and birth outcomes are summarized in Table  1 . Maternal characteristics such as age, gravidity, parity, and presence of labor were similar in all groups. There was also no difference in 5-minute Apgar score. A small but statistically significant difference in mean cord blood pH and base deficit was present between some groups as depicted in Table 1 . No correlation existed between Epo levels and base deficit or birth weight. However, a weak correlation existed between Epo and pH (r ϭ Ϫ0.16, p ϭ 0.034).
As expected, post-term pregnancies (41 to 43 weeks' gestation) had a significantly higher gestational age and birth weight compared with term pregnancies (37 to 40 weeks' gestation).
In meconium-free pregnancies, post-term fetuses had significantly higher cord blood Epo levels compared with term fetuses (50.6 Ϯ 6.5 versus 29.5 Ϯ 3.3 mIU/ml, p ϭ 0.002; Figure 1 ). Furthermore, post-term fetuses with meconium-stained amniotic fluid had significantly higher cord blood Epo levels compared with postterm fetuses without meconium (80.7 Ϯ 15.7 versus 50.6 Ϯ 6.5 mIU/ml, p ϭ 0.021) and term fetuses without meconium (80.7 Ϯ 15.7 versus 29.5 Ϯ 3.3 mIU/ml, p ϭ 0.0001; Figure 1 ). Term fetuses with meconium-stained amniotic fluid had significantly higher cord blood Epo levels compared with fetuses with no meconium (61.4 Ϯ 12.8 versus 29.5 Ϯ 3.3 mIU/ml, p ϭ 0.001; Figure 1) . A separate analysis of all pregnancies with meconium-stained amniotic fluid showed no significant difference in Epo levels between term and postterm fetuses (Figure 2) . Of all the groups studied, the greatest Epo concentrations were found in the post-term group of fetuses with meconium-stained amniotic fluid (80.7 Ϯ 15.7 mIU/ml, Figure 1 ).
DISCUSSION
Despite recent advances in fetal surveillance and neonatal care, postterm fetuses still carry an increased risk of perinatal morbidity. This may be due to factors such as macrosomia, oligohydramnios, and the presence of meconium, which in itself complicates Յ44% of postterm pregnancies. 13 However, much controversy still exits regarding the etiology of meconium passage and the management of these pregnancies. Whereas certain investigators feel that meconium passage is a maturational event, others believe it is more a manifestation of fetal compromise. 13 The question of whether or not these fetuses are distressed remains unanswered. Although some have reported a higher incidence of perinatal mortality in this group, a consistent association between meconium-stained amniotic fluid and fetal acidosis has not been shown in the literature. In fact, several studies have concluded that in the absence of abnormal fetal heart rate patterns, the presence of meconium does not reflect fetal distress. 14, 15 Controversy around the management of post-term fetuses with meconium-stained amniotic fluid points to the need to clearly evaluate the status of these fetuses before making any recommendations. This evaluation involves an assessment of their acid-base and chronic oxygenation status at birth. Because fetal Epo concentrations have been shown to increase within 3 hours of a hypoxic insult 6 and remain elevated for Յ24 hours, 16 EPO represents a marker of subacute hypoxia.
The levels of cord blood Epo observed in our normal term, meconium-free fetuses were similar to those reported in other studies. 17, 18 In agreement with a previous report by Jazayeri et al., 10 our data show significantly higher umbilical cord blood Epo levels in post-term fetuses compared with term fetuses, implying a state of subacute hypoxia in post-term fetuses. The basis of the subacute hypoxia may lie in the discrepancy between fetal and placental growth during this period. Indeed, placental growth plateaus at 36 to 37 weeks, whereas the fetus itself continues to grow. This apparent imbalance might create a state of relative placental insufficiency that could result in decreased oxygen transfer to the fetus. Therefore, to maintain tissue oxygenation, fetal Epo increases, thereby stimulating red blood cell production and improving oxygen delivery. However, because these fetuses depend on this mechanism for the maintenance of oxygenation, they may be in a more precarious situation and more vulnerable to a variety of insults. Our data show that the presence of meconium is associated with elevated cord blood Epo levels both in term and post-term fetuses. This finding is consistent with the observations on term and pre-term fetuses made by Maier et al. 19 Although they could not demonstrate a correlation between Epo and meconium-stained amniotic fluid, they still reported much greater Epo values in fetuses with meconium compared with those without (80.6 versus 28 mU/ml). More recently, Richey et al. reported similar findings. 20 However, the meconium group had a significantly greater gestational age (39.7 Ϯ 1.4 weeks) compared with controls (38.9 Ϯ 1.6 weeks). This implies the presence of more post-term fetuses in the meconium group, which introduces a potential bias. Our results clarify that post-term fetuses display elevated Epo levels and that the presence of meconium-stained amniotic fluid increases these levels even more. The demonstration of high Epo levels in fetuses with meconium-stained amniotic fluid lends support to the theory of fetal compromise/distress in these pregnancies.
Regardless of gestational age, the presence of meconium was consistently associated with elevated Epo levels ( Figure 2 ). This observation suggests that meconium may be a manifestation of a more distressful event to the fetus than postdatism, although both situations can present a threat to fetal well-being in utero as demonstrated by high Epo levels.
Interestingly, fetuses with elevated Epo levels (post-term and meconium) with one exception, displayed clinically normal cord blood pH and base deficits. This may be explained by the fact that these parameters fluctuate rapidly following hypoxia and return to baseline quickly. Therefore, they are better indicators of acute hypoxia, whereas Epo levels, alternatively, are more indicative of subacute hypoxia. This is likely why we found a lack of correlation between base deficit and Epo and a very weak one between Epo and cord blood pH as shown by others. 10, 17, 19, 20 In fact, although small statistical differences were observed in mean cord pH (e.g., pH 7.26 versus pH 7.29) and base deficit (e.g., 5.5 versus 7.1), these are not clinically significant, as these values are all in normal range. Indeed, only the post-term with meconium group had a mean cord pH somewhat lower than the other groups. This may be attributed to the presence of an asphyxiated fetus in this group (pH 6.9). None of the other fetuses studied had clinically abnormal pH (Table 1 ) or base deficit. Cord blood pH, base deficit, and Apgar scores are indirect markers of acute hypoxia and have not been shown to be good predictors of neurologic outcome. Epo, however, has been demonstrated to better predict cerebral palsy and death 11 and represents a useful way to assess the presence of chronic hypoxia.
Our data suggest that post-term fetuses may be at risk for subacute hypoxia, and that this is especially true if they display meconium-stained amniotic fluid. This finding reinforces the need for very close antepartum and intrapartum monitoring of these pregnancies.
